Management of Respiratory Viral Infection in Children
Article Sidebar
Main Article Content
Abstract
Respiratory viral infections are a major cause of morbidity and mortality in children, posing a significant burden on healthcare systems. A proper understanding of the epidemiology, diagnostic methods, and management strategies is essential to improve paediatric care and avoid the unjustified use of antibiotics, thereby contributing to the fight against antimicrobial resistance. Aim: This study aims to provide a comprehensive synthesis of the literature on respiratory viral infections in children, focusing on the role of antibiotics and the importance of preventive measures. Methodology: For this literature review, an initial 87,000 articles were identified from seven databases, following the PRISMA protocol. After removing duplicates and applying exclusion criteria, 200 articles were reviewed, of which 43 were selected for the final synthesis. Results: The study highlights the diversity of viral agents involved, including RSV, influenza viruses, and rhinoviruses. It emphasizes that antibiotics are effective only in cases of bacterial superinfections. Vaccination and hygiene measures are crucial for prevention, while health education plays a central role in reducing infection incidence. Conclusions: Optimal management of respiratory viral infections in children requires a multidisciplinary approach centred on prevention and accurate diagnosis. The study underscores the need for evidence-based protocols, as well as the importance of education and hygiene measures in paediatric communities. These findings provide a solid foundation for developing tailored health policies and contribute to improving clinical practices in paediatrics.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
van Doorn HR, Yu H. Viral respiratory infections. In: Hunter's tropical medicine and emerging infectious diseases. 2020. p. 284–8.doi:10.1016/B978-0-323-55512-8.00033-8
Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047–64.
Zhang S, Akmar LZ, Bailey F, Rath BA, Alchikh M, Schweiger B, et al. Cost of respiratory syncytial virus-associated acute lower respiratory infection management in young children at the regional and global level: a systematic review and meta-analysis. J Infect Dis. 2020;222(Suppl 7):680-7.doi:10.1093/infdis/jiz683
World Health Organization. WHO strategy for the global respiratory syncytial virus surveillance based on influenza surveillance. Geneva: World Health Organization; 2019 [cited 2023 Dec 9]. Available from: https://cdn.who.int/media/docs/default-source/influenza/who-rsv-surveillance-strategy-phase-26mar2021.pdf?sfvrsn=6c9f1ba_1&download=true
Carrico J, Hicks KA, Wilson E, Panozzo CA, Ghaswalla P. The annual economic burden of respiratory syncytial virus in adults in the United States. J Infect Dis. 2024;230(2):342-52.doi:10.1093/infdis/jiad559
Troeger CE, Khalil IA, Blacker BF, Biehl MH, Albertson SB, Zimsen SR, et al. Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis. 2020;20(1):60–79.doi:
Meganck RM, Baric RS. Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases. Nat Med. 2021;27(3):401–10.doi:10.1038/s41591-021-01282-0
Stambas J, Lu C, Tripp RA. Innate and adaptive immune responses in respiratory virus infection: implications for the clinic. Expert Rev Respir Med. 2020;14(11):1141–7.doi:10.1080/17476348.2020.1807945
Shaw ER, Su HC. The influence of immune immaturity on outcome after virus infections. J Allergy Clin Immunol Pract. 2021;9(2):641–50.doi:10.1016/j.jaip.2020.11.016
Zhang XL, Zhang X, Hua W, Xie ZD, Liu HM, Zhang HL, et al. Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children. World J Pediatr. 2024;20(1):11–25.doi:10.1007/s12519-023-00777-9
Geppe NA, Zaplatnikov AL, Kondyurina EG, Chepurnaya MM, Kolosova NG. The common cold and influenza in children: to treat or not to treat? Microorganisms. 2023;11(4):858.doi:10.3390/microorganisms11040858
Al-Harrasi A, Bhatia S. Epidemiology respiratory infections: types, transmission, and risks associated with co-infections. In: Role of essential oils in the management of COVID-19. CRC Press; 2022. p. 7–17.
Balasubramani K, Prasad KA, Kodali NK, Abdul Rasheed NK, Chellappan S, Sarma DK, et al. Spatial epidemiology of acute respiratory infections in children under 5 years and associated risk factors in India: district-level analysis of health, household, and environmental datasets. Front Public Health. 2022;10:906248.doi:10.3389/fpubh.2022.906248
Cortes-Ramirez J, Wilches-Vega JD, Paris-Pineda OM, Rod JE, Ayurzana L, Sly PD. Environmental risk factors associated with respiratory diseases in children with socioeconomic disadvantage. Heliyon. 2021;7(4).
Islam M, Islam K, Dalal K, Hossain Hawlader MD. In-house environmental factors and childhood acute respiratory infections in under-five children: a hospital-based matched case-control study in Bangladesh. BMC Pediatr. 2024;24(1):38.doi:10.1186/s12887-024-04525-4
Hou J, Lv D, Sun Y, Wang P, Zhang Q, Sundell J. Children’s respiratory infections in Tianjin area, China: associations with home environments and lifestyles. Int J Environ Res Public Health. 2020;17(11):4069.doi:10.3390/ijerph17114069
Suryadevara M, Domachowske JB. Epidemiology and seasonality of childhood respiratory syncytial virus infections in the tropics. Viruses. 2021;13(4):696.doi:10.3390/v13040696
Chadha M, Hirve S, Bancej C, Barr I, Baumeister E, Caetano B, et al. Human respiratory syncytial virus and influenza seasonality patterns—early findings from the WHO global respiratory syncytial virus surveillance. Influenza Other Respir Viruses. 2020;14(6):638–46.doi:10.1111/irv.12726
Thongpan I, Vongpunsawad S, Poovorawan Y. Respiratory syncytial virus infection trend is associated with meteorological factors. Sci Rep. 2020;10(1):10931.doi:10.1038/s41598-020-67969-5
Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment, and prevention options in children. Pediatr Infect Dis J. 2020;39(5):355–68.doi:10.1097/INF.0000000000002660
Wang X, Li Y, O'Brien KL, Madhi SA, Widdowson MA, Byass P, et al. Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study. Lancet Glob Health. 2020;8(4): e497-e510.doi:
Basa M, Sovtić A. Treatment of the most common respiratory infections in children. Arch Pharm. 2022;72(Notebook 3):275–99.doi:10.5937/arhfarm72-37857
Zhao H, Jiang X, Lu L, Lin Q. New progress in clinical diagnosis, treatment and laboratory testing of acute respiratory infections in children. Am J Mol Biol. 2022;12(1):1–9.doi:10.4236/ajmb.2022.121001
Douros K, Everard ML. Time to say goodbye to bronchiolitis, viral wheeze, reactive airways disease, wheeze bronchitis and all that. Front Pediatr. 2020;8:218.doi:10.3389/fped.2020.00218
Biary N, Desai P. Bronchiolitis. In: Pediatric rotations: a quick guide for medical students. Cham: Springer International Publishing; 2024. p. 147–53.
Haddadin Z, Beveridge S, Fernandez K, Rankin DA, Probst V, Spieker AJ, et al. Respiratory syncytial virus disease severity in young children. Clin Infect Dis. 2021;73(11):e4384-e4391.doi:10.1093/cid/ciaa1612
Jung J, Seo E, Yoo RN, Sung H, Lee J. Clinical significance of viral–bacterial codetection among young children with respiratory tract infections: findings of RSV, influenza, adenoviral infections. Medicine (Baltimore). 2020;99(2):e18504.doi:10.1097/MD.0000000000018504
Streng A, Prifert C, Weissbrich B, Sauerbrei A, Krumbholz A, Schmidt-Ott R, et al. Similar severity of influenza primary and re-infections in pre-school children requiring outpatient treatment due to febrile acute respiratory illness: prospective, multicentre surveillance study (2013–2015). BMC Infect Dis. 2022;22(1):12.doi:10.1186/s12879-021-06988-7
Macías Reyes MJ, Vidal-Alaball J, Suwezda EA, Miró Catalina Q, Homs M, Ruiz-Comellas A. Prevalence of respiratory infections during the 2018–2020 period in the paediatric population of primary care centres in central Catalonia. Healthcare (Basel). 2023;11(9):1252.doi:10.3390/healthcare11091252
Temte JL, Barlow S, Goss M, Temte E, Bell C, He C, et al. The Oregon child absenteeism due to respiratory disease study (ORCHARDS): rationale, objectives, and design. Influenza Other Respir Viruses. 2022;16(2):340–50.doi:10.1111/irv.12920
Paul J. Respiratory tract infections. In: Disease causing microbes. Cham: Springer International Publishing; 2024. p. 99–148.doi:10.1007/978-3-031-28567-7_3
Das CS. Acute respiratory ailments in pediatric age group and role of CRP in diagnosis and management. Clin Signif C-reactive Protein. 2020;213–48.doi:10.1007/978-981-15-6787-2_8
George K, Govindaraj G. Infections in inborn errors of immunity with combined immune deficiency: a review. Pathogens. 2023;12(2):272.doi:10.3390/pathogens12020272
Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr. 2020;174(9):882–9.doi:10.1001/jamapediatrics.2020.1467
Tsoi K, Chan KC, Chan L, Mok G, Li AM, Lam HS. A child with SARS-CoV2-induced croup. Pediatr Pulmonol. 2021;56(7):2377.doi:10.1002/ppul.25408
Buonsenso D, Musolino A, Ferro V, De Rose C, Morello R, Ventola C, et al. Role of lung ultrasound for the etiological diagnosis of acute lower respiratory tract infection (ALRTI) in children: a prospective study. J Ultrasound. 2022;25(2):185–97.doi:10.1007/s40477-021-00600-z
Chen ZM, Fu JF, Shu Q, Chen YH, Hua CZ, Li FB, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr. 2020;16:240–6.doi:10.1007/s12519-020-00345-5
Cohen R, Haas H, Romain O, Béchet S, Romain C, de Lays CDT, et al. Use of rapid antigen triple test nasal swabs (COVID-VIRO ALL-IN TRIPLEX: Severe Acute Respiratory Syndrome Coronavirus 2, Respiratory Syncytial Virus, and Influenza) in children with respiratory symptoms: a real-life prospective study. Open Forum Infect Dis. 2024;11(1):617.doi:10.1093/ofid/ofad617
Lin CY, Hwang D, Chiu NC, Weng LC, Liu HF, Mu JJ, et al. Increased detection of viruses in children with respiratory tract infection using PCR. Int J Environ Res Public Health. 2020;17(2):564.doi:10.3390/ijerph17020564
Stefanidis K, Konstantelou E, Yusuf GT, Oikonomou A, Tavernaraki K, Karakitsos D, et al. Radiological, epidemiological and clinical patterns of pulmonary viral infections. Eur J Radiol. 2021;136:109548.doi:10.1016/j.ejrad.2021.109548
Pichichero ME, Chapman TJ, Bajorski P. Pneumonia, sinusitis, influenza and other respiratory illnesses in acute otitis media–prone children. Pediatr Infect Dis J. 2021;40(11):975–80.doi:10.1097/INF.0000000000003228
Meskill SD, O’Bryant SC. Respiratory virus co-infection in acute respiratory infections in children. Curr Infect Dis Rep. 2020;22:1–8.doi:10.1007/s11908-020-0711-8
Rossi GA, Fanous H, Colin AA. Viral strategies predisposing to respiratory bacterial superinfections. Pediatr Pulmonol. 2020;55(4):1061–73.doi:10.1002/ppul.24699
Musuuza JS, Watson L, Parmasad V, Putman-Buehler N, Christensen L, Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLoS One. 2021;16(5):e0251170.doi:10.1371/journal.pone.0251170
Tomić M, Pecikoza U. Medications and non-pharmacological measures to alleviate the symptoms of respiratory tract infections in the pediatric population. Arch Pharm. 2022;72(Notebook 3):300–19.doi:10.5937/arhfarm72-38025
Osarogiagbon OW, Ayuk AC, Meremikwu M, Oguonu T, Umar LW, Garba IB, et al. Management of community-acquired pneumonia (CAP) in children: clinical practice guidelines by the Paediatric Association of Nigeria (PAN). Niger J Paediatr. 2022;49(3):210–39.doi:
Sun P, Zhang J, Cheng F, Gao Y, Fu Z, Liu S, et al. Clinical treatment of COVID-19. Clin Diagn Treat New Coronavirus Pneumonia. 2020;61–96.doi:10.1016/j.jinf.2020.03.041
Tripp RA, Martin DE. Antiviral agents and therapeutics against respiratory viruses. Expert Opin Investig Drugs. 2024;1–5.doi:10.1080/13543784.2024.240191
Kumari R, Sharma SD, Kumar A, Ende Z, Mishina M, Wang Y, et al. Antiviral approaches against influenza virus. Clin Microbiol Rev. 2023;36(1):e00040-22.doi:10.1128/cmr.00040-22
Yousefi B, Valizadeh S, Ghaffari H, Vahedi A, Karbalaei M, Eslami M. A global treatments for coronaviruses including COVID-19. J Cell Physiol. 2020;235(12):9133–42.doi:10.1002/jcp.29785
Praud JP. Long-term non-invasive ventilation in children: current use, indications, and contraindications. Front Pediatr. 2020;8:584334.doi:10.3389/fped.2020.584334
Mazur NI, Caballero MT, Nunes MC. Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies. Lancet. 2024;404(10458):1143–56.
Urbani F, Cometa M, Martelli C, Santoli F, Rana R, Ursitti A, et al. Update on virus-induced asthma exacerbations. Expert Rev Clin Immunol. 2023;19(10):1259–72.doi:10.1080/1744666X.2023.2239504
Oseghale O, Vlahos R, O’Leary JJ, Brooks RD, Brooks DA, Liong S, et al. Influenza virus infection during pregnancy as a trigger of acute and chronic complications. Viruses. 2022;14(12):2729.doi:10.3390/v14122729
Na'amnih W, Kassem E, Tannous S, Kagan V, Jbali A, Hanukayev E, et al. Incidence and risk factors of hospitalisations for respiratory syncytial virus among children aged less than 2 years. Epidemiol Infect. 2022;150:e45.doi:10.1017/S0950268822000152
Hothan KA, Alawami MA, Baothman EA, Alghanem FA, Al-Haddad DM, Al Daerwish RI, et al. Types of upper and lower respiratory tract infection in pediatrics. Int J Community Med Public Health. 2022;9:4689.doi:10.18203/2394-6040.ijcmph20223231
Piradashvili N, Tabidze B. Influenza & respiratory virus epidemiological characteristics among children in Georgia. Health Policy Econ Sociol. 2023;7(1):1–10.
Golden A, Cantera JL, Lillis L, Phan TT, Slater H, Webb EJ, et al. A reagent and virus benchmarking panel for a uniform analytical performance assessment of N antigen-based diagnostic tests for COVID-19. Microbiol Spectr. 2023;11(3):e03731-22.doi:10.1128/spectrum.03731-22
Pan Y, Long L, Zhang D, Yuan T, Cui S, Yang P, et al. Potential false-negative nucleic acid testing results for severe acute respiratory syndrome coronavirus 2 from thermal inactivation of samples with low viral loads. Clin Chem. 2020;66(6):794–801.doi:10.1093/clinchem/hvaa091
Bassetti S, Tschudin-Sutter S, Egli A, Osthoff M. Optimizing antibiotic therapies to reduce the risk of bacterial resistance. Eur J Intern Med. 2022;99:7–12.doi:10.1016/j.ejim.2022.01.029
Motisi MA, Tamborino A, Parigi S, Galli L, de Martino M, Chiappini E. The use of antiviral drugs in children. J Chemother. 2022;34(2):73–86.doi:10.1080/1120009X.2021.1979746
Ferreyro BL, Angriman F, Munshi L, Del Sorbo L, Ferguson ND, Rochwerg B, et al. Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure: a systematic review and meta-analysis. JAMA. 2020;324(1):57–67.doi:10.1001/jama.2020.9524
Tsao YT, Tsai YH, Liao WT, Shen CJ, Shen CF, Cheng CM. Differential markers of bacterial and viral infections in children for point-of-care testing. Trends Mol Med. 2020;26(12):1118–32.
Los-Arcos I, Iacoboni G, Aguilar-Guisado M, Alsina-Manrique L, Diaz de Heredia C, Fortuny-Guasch C, et al. Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper. Infection. 2021;49:215–31.doi:10.1007/s15010-020-01521-5
Amin MT, Abd El Aty MA, Ahmed SM, Elsedfy GO, Hassanin ES, El-Gazzar AF. Over prescription of antibiotics in children with acute upper respiratory tract infections: a study on the knowledge, attitude and practices of non-specialized physicians in Egypt. PLoS One. 2022;17(11):e0277308.doi:10.1371/journal.pone.0277308
Houglum JE, Harrelson GL, Seefeldt TM. Drugs for treating infections. In: Principles of pharmacology for athletic trainers. Routledge; 2024. p. 74–95.
Mejias A, Rodríguez-Fernández R, Oliva S, Peeples ME, Ramilo O. The journey to a respiratory syncytial virus vaccine. Ann Allergy Asthma Immunol. 2020;125(1):36–46.doi:10.1016/j.anai.2020.03.017
Gozdzielewska L, Kilpatrick C, Reilly J, Stewart S, Butcher J, Kalule A, et al. The effectiveness of hand hygiene interventions for preventing community transmission or acquisition of novel coronavirus or influenza infections: a systematic review. BMC Public Health. 2022;22(1):1283.doi:10.1186/s12889-022-13667-y
Klein JD, Koletzko B, El-Shabrawi MH, Hadjipanayis A, Thacker N, Bhutta Z. Promoting and supporting children’s health and healthcare during COVID-19–International Paediatric Association position statement. Arch Dis Child. 2020;105(7):620–4.doi:10.1136/archdischild-2020-319370